Duco Launches Next-Gen AI Automation at SIBOS
As regulatory deadlines accelerate and data volumes explode, Duco is arming financial institutions with smarter, faster and easier ways to automate. Today Duco introduces AI-powered rules that anyone can build, automated ingestion for any file format, and real time assurance for T+1 settlement readiness in the UK/EU.
Agentic Rule Builder
Duco’s new Agentic Rule Builder is the next step in no-code automation. The company’s Natural Rule Language (NRL) already allowed non-coders to create rules in plain English (‘if X is true then set Y’). But as data and processes grow more complex, even no-code systems require training and become harder to manage.
The Agentic Rule Builder addresses this by letting users describe actions and outcomes the way they would to a colleague. Using a plain English prompt, they can generate and refine NRL rules, edit specific sections, and apply consistent changes across multiple rules.
The tool’s agents map a plan for the rule, build and validate it, and render it in the interface for human validation and full transparency. Early client testing suggests it can cut rule-creation time by half and speed up automation by 60-75%, speeding time to market.
Enhanced AI-Native Data Prep
Building on AIDP – Adaptive Intelligent Document Processing (which intelligently extracts information from PDFs, images, Word files and emails) – this new form of processing learns from content and context, increasing resiliency. Traditional parsing doesn’t take context into account.
Duco has enhanced AI-Native data prep by extending flexible ingestion, enabling low training extraction for faster set up and incorporating Agentic rule builder into the solution. This enables clients to automate more, increase straight through processing, and achieve greater accuracy than with traditional OCR/IDP tools or LLMs alone. All integrated in the Duco platform, eliminating the need for multiple tools in clients' tech stacks.
“AI-powered automation is moving beyond task support to shape how businesses operate,” said Justin Hingorani, Managing Director, AI and Data Prep. “This evolution is not just about speed or efficiency. It is about empowering organisations to respond to client needs and market challenges with agility and confidence. Intelligent automation and industry know-how turn complex post-trade processes into simple, transparent workflows. OCR and IDP were built for static formats. They break the moment data shifts. Our AI-native approach adapts in real time, making it the only sustainable path forward.”
T+0 Assurance Controls for Settlement Evolution
To meet the challenges of T+1 settlement, Duco is launching the only truly cloud-native, AI-native, no code T+0 assurance controls for clients in the UK and Europe. These controls, developed for the North America move to T+1 settlement in 2024, enable clients to move to intra-day, T+0 reconciliations and exception management.
Evidence from last year’s transition shows increasing headcount – in some cases by as much as 18% – doesn’t have a significant impact on fail rates. And with a more than 80% reduction in operational post-trade processing times, manual work – even as the exception – will be untenable. Intra-day reconciliation and exception management will have to become the norm. T+1 requires firms to improve automation capabilities that will support a T+0 operating model.
“The move to T+1 settlement is one of the most significant operational shifts our industry has faced in decades,” said Steve Walsh, Managing Director, Reconciliation. “We’re using critical lessons from North America to ensure the transition in Europe does not require additional headcount. Instead by cutting reconciliation time, firms also create a scalable, future-proof operating model for post-trade processing.”
James Maxfield, Chief Product Officer at Duco, said: “We are moving into an era where automation is not just faster or easier, but smarter and adaptive. Today, our AI agents support rule creation and reconciliation. Soon, they’ll help with anomaly detection, exception management and orchestration of entire processes – always with human oversight where clients need it. This is how firms can build resilience, cut complexity and stay ahead of compressed regulatory deadlines.”
About Duco
Duco is empowering financial services firms to break the bad data cycle that has held the industry back for decades.
We do this with a combination of proprietary technique, innovative cloud computing, no-code and artificial intelligence technology, and deep subject matter expertise.
Our AI-powered operational data automation platform gives firms the ability to unlock full end-to-end reconciliation and automation of their data, regardless of source, format or structure.
By partnering with the industry’s leading firms, we are helping to rethink operating models, increase efficiency, strengthen governance and regulatory compliance, reduce risk, streamline processes and build the workforce of the future.
Over 10,000 users across 30+ countries process billions of data records every week using the platform.
Duco is headquartered in London, with offices in New York, Wroclaw, Antwerp and Singapore. Customers include global banks, investment managers, exchanges and insurance firms, such as CIBC, ING and Man Group. For more information go to www.du.co.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250929875030/en/
Contacts
Greg Noble
greg.noble@cognitomedia.com
Senior Account Executive, Cognito Media
+447983268447
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
Safe Software Recognized as a Niche Player in 2025 Gartner® Magic Quadrant™ for Data Integration Tools15.12.2025 12:00:00 CET | Press Release
Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report. Safe Software’s FME Platform has evolved well beyond its geospatial roots to become the only All-Data, Any-AI Integration Platform, empowering organizations worldwide to connect all data, applications, and AI technologies anywhere, at any scale, and with complete flexibility. With a community of more than 200,000 enthusiastic users and 25,000+ organizations in over 125 countries, FME continues to redefine data integration by delivering a no-code enterprise solution that unifies data movement, automation, and AI connectivity. “Our continued recognition reflects the trust of our customers and the innovation of our team,” said Don Murray, CEO and Co-Founder of Safe Software. “We’re proud to help organizations integrate data seamlessl
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c
BitGo yn Sicrhau Cymeradwyaeth OCC i Drosi i Fanc Ymddiriedolaeth Genedlaethol Siartredig Ffederal13.12.2025 02:13:00 CET | Pressmeddelande
Cyhoeddodd BitGo Holdings, Inc. (“BitGo”), y cwmni seilwaith asedau digidol, heddiw fod Swyddfa Rheolwr yr Arian Cyfred (“OCC”) wedi cymeradwyo ei gais i drosi BitGo Trust Company, Inc., cwmni ymddiriedolaeth siartredig De Dakota, i fanc cenedlaethol o'r enw BitGo Bank & Trust, National Association (N.A.). Gyda chymeradwyaeth OCC heddiw o'i drosi, mae is-gwmni Cwmni Ymddiriedolaeth BitGo bellach yn gweithredu fel BitGo Bank & Trust, National Association (N.A.). Bydd BitGo Bank & Trust, N.A. yn gweithredu o dan un gyfundrefn oruchwylio ffederal unffurf, gan ei alluogi i ddarparu'r eglurder, y llywodraethiant, a'r sicrwydd rheoleiddiol y mae sefydliadau'n eu disgwyl gan ymddiriedolwr a reoleiddir yn ffederal. Mae'r gymeradwyaeth hon yn atgyfnerthu safle BitGo fel sylfaen sefydliadol ar gyfer y system ariannol fodern, gan gyfuno goruchwyliaeth ar lefel banc â'r diogelwch, y cydymffurfiaeth, a'r graddadwyedd sy'n diffinio seilwaith BitGo. O dan siarter y banc cenedlaethol, ac yn amodol ar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom